XTL BIOPHARMACEUTICALS LTD. Profit Loss Attributable To Noncontrolling Interests
XTL BIOPHARMACEUTICALS LTD. (XTLB) reported Profit Loss Attributable To Noncontrolling Interests of -$1.35 million for the 12-month period ending 2019-12-31, per its 20-F filed 2020-03-12.
Discontinued › Notes
ifrs-full:ProfitLossAttributableToNoncontrollingInterests · last filed 2020-03-12
| Period end | Profit Loss Attributable To Noncontrolling Interests 12 month |
|---|---|
| 2019-12-31 | -$1.35M 20-F · filed 2020-03-12 |
| 2018-12-31 | $2.99M 20-F · filed 2020-03-12 |
| 2017-12-31 | -$781.00K 20-F · filed 2020-03-12 |
| 2016-12-31 | -$2.54M 20-F · filed 2019-03-11 |
| 2015-12-31 | -$4.31M 20-F · filed 2018-03-15 |